Perfusion Bioreactor Market

Perfusion is a means to maintain a cell culture bioreactor in which equivalent volumes of media are simultaneously added and removed from the reactor while the cells are retained in the reactor.

Perfusion bioreactors offer several advantages over traditional fed-batch bioreactors when addressing problems of scalability and increasing demand.

Perfusion bioreactors culture cells over much longer periods, even months, by continuously feeding the cells with fresh media and removing spent media while keeping cells in culture. In perfusion there are different ways to keep the cells in culture while removing spent media.

Perfusion Bioreactor Market contains market size and forecasts of Perfusion Bioreactor in global, including the following market information:

Global Perfusion Bioreactor Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Perfusion Bioreactor Market Sales, 2017-2022, 2023-2028, (Units)

Global top five Perfusion Bioreactor companies in 2021 (%)

The global Perfusion Bioreactor market was valued at 696.6 million in 2021 and is projected to reach US$ 1265.3 million by 2028, at a CAGR of 8.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Small Scale (Less Than 100 Liters) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Perfusion Bioreactor include Sartorius AG, Thermo Fisher, GE Healthcare Life Sciences, Pall, Eppendorf AG, ZETA, 3D Biotek, Infors HT and Applikon Biotechnology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Perfusion Bioreactor manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Perfusion Bioreactor Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Perfusion Bioreactor Market Segment Percentages, by Type, 2021 (%)

• Small Scale (Less Than 100 Liters)
• Mid-Scale (100 Liters to 1,000 Liters)
• Large Scale (More Than 1,000 Liters)

Global Perfusion Bioreactor Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Perfusion Bioreactor Market Segment Percentages, by Application, 2021 (%)

• Biopharmaceutical
• Biotechnology
• Others

Global Perfusion Bioreactor Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Perfusion Bioreactor Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Perfusion Bioreactor revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Perfusion Bioreactor revenues share in global market, 2021 (%)
• Key companies Perfusion Bioreactor sales in global market, 2017-2022 (Estimated), (Units)
• Key companies Perfusion Bioreactor sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sartorius AG
• Thermo Fisher
• GE Healthcare Life Sciences
• Pall
• Eppendorf AG
• ZETA
• 3D Biotek
• Infors HT
• Applikon Biotechnology
• Bioengineering AG
• PBS Biotech, Inc.
• Cell Culture Company
• Zellwerk GmbH